Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-04-30T13:58:02.887Z Has data issue: false hasContentIssue false

Chapter 2 - Ovulation Induction for Anovulatory Patients

from Section 1 - Mild Forms of Ovarian Stimulation

Published online by Cambridge University Press:  14 April 2022

By
Evert J. P. van Santbrink  and
Bart C. J. M. Fauser
Edited by
Mohamed Aboulghar  and
Botros Rizk
Mohamed Aboulghar
Affiliation:
University of Cairo IVF Centre
Botros Rizk
Affiliation:
University of South Alabama
Get access

Summary

The lack of ovulatory cycles may be considered as a major problem for women seeking pregnancy. This is reflected by the fact that about 20 percent of couples visiting a fertility clinic with an unfulfilled wish to conceive present with anovulation [1]. Clinical manifestation of anovulation is oligomenorrhea (intermenstrual period > 35 days) or amenorrhea (intermenstrual period > 6 months). Although ovulation may occur in oligomenorrhea, the longer the time period between menstruations the smaller the chance of that cycle being ovulatory. Classification of anovulatory patients may be performed using the criteria of the World Health Organization (WHO) as determined by Rowe et al.

Type
Chapter
Information
Ovarian Stimulation , pp. 15 - 28
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Balen, AH, Rutherford, AJ. Managing anovulatory infertility and polycystic ovary syndrome. BMJ 2007;335:663–666.Google Scholar
Rowe, PJ, Combaire, FH, Hargreave, TB, et al. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Cambridge, Mass.: Cambridge University Press; 2001.Google Scholar
Van Santbrink, EJ, Hop, WC, Fauser, BC. Classification of nomogonadotrophic anovulatory infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 1997;67:453–458.CrossRefGoogle Scholar
Stein, IF, Leventhal, ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181–191.Google Scholar
Zawadski, JK, Dunaif, A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif, A, Givens, JR, Haseltine, F, eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific; 1992:377–384.Google Scholar
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–47.Google Scholar
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril 2004;81:19–25.Google Scholar
Azziz, R, Carmina, E, Dewailly, D, et al.; Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237–4245.Google Scholar
Franks, S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 2006;91:786–789.CrossRefGoogle ScholarPubMed
ESHRE Capri Workshop Group. Mono-ovulatory cycles: a key goal in profertility programmes. Hum Reprod Update 2003;9:263–274.CrossRefGoogle Scholar
Kiddy, DS, Sharp, PS, White, DM, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) 1990;32:213–220.Google Scholar
Franks, S, Kiddy, D, Sharp, P, et al. Obesity and polycystic ovary syndrome. Ann N Y Acad Sci 1991;626:201–206.CrossRefGoogle ScholarPubMed
Rich-Edwards, JW, Spiegelman, D, Garland, M, et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology 2002;13:184–190.CrossRefGoogle ScholarPubMed
Norman, RJ, Davies, MJ, Lord, J, Moran, LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002;13:251–257.CrossRefGoogle ScholarPubMed
Wang, JX, Davies, MJ, Norman, RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002;10:551–554.Google Scholar
Dietl, J. Maternal obesity and complications during pregnancy. J Perinat Med 2005;33:100–105.Google Scholar
Boomsma, CM, Fauser, BC, Macklon, NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;26:72–84.CrossRefGoogle ScholarPubMed
Valkenburg, O, Steegers-Theunissen, RP, Smedts, HP, et al. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab 2008;93:470–476.Google Scholar
Kiddy, DS, Hamilton-Fairley, D, Bush, A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;36:105–111.CrossRefGoogle ScholarPubMed
Clark, AM, Thornley, B, Tomlinson, L, Galletley, C, Norman, RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998;13:1502–1505.CrossRefGoogle ScholarPubMed
Hoeger, KM. Role of lifestyle modification in the management of polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2006;20:293–310.Google Scholar
Yanovski, SZ, Yanovski, JA. Obesity. N Engl J Med 2002;346:591–602.Google Scholar
Sjöström, L, Lindroos, AK, Peltonen, M, et al.; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683–2693.Google Scholar
Wadden, TA, Berkowitz, RI, Womble, LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005;353:2111–2120.CrossRefGoogle ScholarPubMed
Balen, AH, Dresner, M, Scott, EM, et al. Should obese women with polycystic ovary syndrome receive treatment for infertility? BMJ 2006;332:434–435.Google Scholar
Nelson, SM, Fleming, RF. The preconceptual contraception paradigm: obesity and infertility. Hum Reprod 2007;22:912–915.Google Scholar
Cooper, GS, Baird, DD, Hulka, BS, et al. Follicle-stimulating hormone concentrations in relation to active and passive smoking. Obstet Gynecol 1995;85:407–411.Google Scholar
El-Nemr, A, Al-Shawaf, T, Sabatini, L, et al. Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer. Hum Reprod 1998;13:2192–2198.CrossRefGoogle ScholarPubMed
Freour, T, Masson, D, Mirallie, S, et al. Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online 2008;16:96–102.Google Scholar
Sammel, MD, Freeman, EW, Liu, Z, Lin, H, Guo, W. Factors that influence entry into stages of the menopausal transition. Menopause 2009;16:1218–1227.Google Scholar
Sharara, FI, Beatse, SN, Leonardi, MR, et al. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the CC challenge test. Fertil Steril 1995;62:257–262.Google Scholar
Winter, E, Wang, J, Davies, MJ, Norman, R. Early pregnancy loss following assisted reproductive technology treatment. Hum Reprod 2002;17:3220–3223.Google Scholar
Saraiya, M, Berg, CJ, Kendrick, JS, et al. Cigarette smoking as a risk factor for ectopic pregnancy. Am J Obstet Gynecol 1998;178:493–498.Google Scholar
Moran, LJ, Noakes, M, Clifton, PM, et al. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:812–819.Google Scholar
Stamets, K, Taylor, DS, Kunselman, A, et al. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril 2004;81:630–637.CrossRefGoogle ScholarPubMed
Reaven, GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 2005;25:391–406.Google Scholar
Crosignani, PG, Colombo, M, Vegetti, W, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 2003;18:1928–1932.CrossRefGoogle ScholarPubMed
Moran, LJ, Brinkworth, G, Noakes, M, Norman, RJ. Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online 2006;12:569–578.Google Scholar
Knowler, WC, Barrett-Connor, E, Fowler, SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.Google Scholar
Wiksten-Almströmer, M, Hirschberg, AL, Hagenfeldt, K. Prospective follow-up of menstrual disorders in adolescence and prognostic factors. Acta Obstet Gynecol Scand 2008;87:1162–1168.Google Scholar
Filicori, M. Gonadotrophin-releasing hormone agonists. A guide to use and selection. Drugs 1994;48:41–58.Google Scholar
Beckers, NG, Platteau, P, Eijkemans, MJ, et al. The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eur J Endocrinol 2006;155:355–363.Google Scholar
Mitwally, MF, Casper, RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 2001;75:305–309.Google Scholar
Teede, HJ, Misso, ML, Costello, MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril 2018;110:364–379.Google Scholar
Garcia-Velasco, JA, Moreno, L, Pacheco, A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 2005;84:82–87.Google Scholar
Biljan, MM, Hemmings, R, Brassard, N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril 2005;84:O-231 abstract 1033.Google Scholar
Tulandi, T, Martin, J, Al-Fadhli, R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006;85:1761–1765.Google Scholar
Tatsumi, T, Jwa, SC, Kuwahara, A, et al. No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in ART. Hum Reprod 2017;32:125–132.Google Scholar
Wang, R, Kim, BV, van Wely, M, et al. Treatment strategies for women with WHO group II anovulation: systemic review and network meta-analysis. BMJ 2017;356:j138.CrossRefGoogle Scholar
Pildes, RB. Induction of ovulation with clomiphene. Am J Obstet Gynecol 1965;91:466–479.Google Scholar
Dehbashi, S, Vafaei, H, Parsanezhad, MD, Alborzi, S. Time of initiation of clomiphene citrate and pregnancy rate in polycystic ovarian syndrome. Int J Gynaecol Obstet 2006;93:44–48.Google Scholar
Moll, E, Bossuyt, PM, Korevaar, JC, Lambalk, CB, van der Veen, F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ 2006;332:1485.CrossRefGoogle ScholarPubMed
Legro, RS, Barnhart, HX, Schlaff, WD, et al.; Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551–566.CrossRefGoogle ScholarPubMed
Daly, DC, Walters, CA, Soto-Albors, CE, Tohan, N, Riddick, DH. A randomized study of dexamethasone in ovulation induction with clomiphene citrate. Fertil Steril 1984;41:844–848.Google Scholar
Kousta, E, White, DM, Franks, S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997;3:359–365.Google Scholar
Imani, B, Eijkemans, MJ, te Velde, ER, Habbema, JD, Fauser, BC. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998;83:2361–2365.Google Scholar
Homburg, R. Clomiphene citrate–end of an era? A mini-review. Hum Reprod 2005;20:2043–2051.CrossRefGoogle Scholar
Rossing, MA, Daling, JR, Weiss, NS, Moore, DE, Self, SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771–776.CrossRefGoogle Scholar
Roumen, FJ, Doesburg, WH, Rolland, R. Treatment of infertile women with a deficient postcoital test with two antiestrogens: clomiphene and tamoxifen. Fertil Steril 1984;41:237–243.Google Scholar
Boostanfar, R. A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction. Fertil Steril 2001;75:1024–1026.Google Scholar
Bayram, N, van Wely, M, van Der Veen, F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2001;2:CD002121.Google Scholar
van Santbrink, EJ, Fauser, BC. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. J Clin Endocrinol Metab 1997;82:3597–3602.Google Scholar
Christin-Maitre, S, Hugues, JN; Recombinant FSH Study Group. A comparative randomized multicentric study comparing the step-up versus step-down protocol in polycystic ovary syndrome. Hum Reprod 2003;18:1626–1631.Google Scholar
van Santbrink, EJ, Eijkemans, MJ, Laven, JS, Fauser, BC. Patient-tailored conventional ovulation induction algorithms in anovulatory infertility. Trends Endocrinol Metab 2005;16:381–389.Google Scholar
Mulders, AG, Eijkemans, MJ, Imani, B, et al. Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod Biomed Online 2003;7:48–56.Google Scholar
Fauser, BC, Devroey, P, Macklon, NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 2005;365:1807–1816.CrossRefGoogle ScholarPubMed
Aboulghar, MA, Mansour, RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 2003;9:275–289.Google Scholar
De Geyter, C, De Geyter, M, Castro, E, et al. Experience with transvaginal ultrasound-guided aspiration of supernumerary follicles for the prevention of multiple pregnancies after ovulation induction and intrauterine insemination. Fertil Steril 1996;65:1163–1168.CrossRefGoogle ScholarPubMed
la Marca, A, Morgante, G, Palumbo, M, et al. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertil Steril 2002;78:1234–1239.Google Scholar
Coffler, MS, Patel, K, Dahan, MH, et al. Enhanced granulosa cell responsiveness to follicle-stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone. J Clin Endocrinol Metab 2003;88:5624–5631.CrossRefGoogle ScholarPubMed
Lord, JM, Flight, IH, Norman, RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003;327:951–953.Google Scholar
Palomba, S, Orio, F Jr., Nardo, LG, et al. Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab 2004;89:4801–4809.Google Scholar
Morley, LC, Tang, T, Yasmin, E, Norman, RJ, Balen, AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2017;11:CD003053.Google Scholar
Legro, RS, Zaino, RJ, Demers, LM, et al. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome. Am J Obstet Gynecol 2007;196:402.e1–402.e10; discussion 402.e10.Google Scholar
Glueck, CJ, Goldenberg, N, Pranikoff, J, et al. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004;19:1323–1330.Google Scholar
Pundir, J, Psaroudakis, D, Savnur, P, et al. Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG 2018;125:299–308.Google Scholar
Stein, IF, Cohen, MR, Elson, R. Results of bilateral ovarian wedge resection in 47 cases of sterility; 20 year end results; 75 cases of bilateral polycystic ovaries. Am J Obstet Gynecol 1949;58:267–274.Google Scholar
Mahesh, VB, Greenblatt, RB. Urinary steroid excretion patterns in hirsutism. II. Effect of ovarian stimulation with human pituitary FSH on urinary 17-ketosteroids. J Clin Endocrinol Metab 1964;24:1293–1302.CrossRefGoogle ScholarPubMed
Gjönnaess, H. Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil Steril 1984;41:20–25.CrossRefGoogle ScholarPubMed
Greenblatt, EM, Casper, RF. Laparoscopic ovarian drilling in women with polycystic ovarian syndrome. Prog Clin Biol Res 1993;381:129–138.Google ScholarPubMed
Farquhar, C, Lilford, RJ, Marjoribanks, J, et al. Laparoscopic ‘drilling’ by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2007;18:CD001122.Google Scholar
Youssef, H, Atallah, MM. Unilateral ovarian drilling in polycystic ovarian syndrome: a prospective randomized study. Reprod Biomed Online 2007;15:457–462.Google Scholar
Saleh, AM, Khalil, HS. Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2004;83:614–621.Google Scholar
Seow, KM, Juan, CC, Hwang, JL, Ho, LT. Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects. Semin Reprod Med 2008;26:101–110.Google Scholar
Overbeek, A, Kuijper, EA, Hendriks, ML, et al. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome. Hum Reprod 2009;24:2007–2013.CrossRefGoogle ScholarPubMed
Practice Committee of the American Society of Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril 2006;86:S178–S183.Google Scholar
Dickey, RP, Taylor, SN, Lu, PY, et al. Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4,062 intrauterine insemination cycles. Fertil Steril 2005;83:671–683.CrossRefGoogle Scholar
White, DM, Polson, DW, Kiddy, D, et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 1996;81:3821–3824.Google Scholar
Mulders, AM, Laven, JS, Eijkemans, MJ, Hughes, EG, Fauser, BC. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Hum Reprod Update 2003;9(5):429–449.Google Scholar
Franik, S, Eltrop, SM, Kremer, JAM, Kiesel, L, Farquhar, C. Aromatase inhibitors for subfertile women with polycystic ovary syndrome. Cochrane Database Syst Rev 2018;5:CD010287.Google ScholarPubMed
Eijkemans, MJ, Imani, B, Mulders, AG, Habbema, JD, Fauser, BC. High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod 2003;18:2357–2362.CrossRefGoogle ScholarPubMed
Imani, B, Eijkemans, MJ, te Velde, ER, Habbema, JD, Fauser, BC. A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 2002;77:91–97.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×